Repare Therapeutics Inc. (NASDAQ:RPTX – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 1,130,000 ...

A downtrend has been apparent in Repare Therapeutics Inc. (RPTX) lately. While the stock has lost 7.6% over the past four ...

Repare Therapeutics Inc. (RPTX) stock has tumbled to a 52-week low, touching down at $1.2 as the biotechnology firm faces a challenging market environment. With a market capitalization of just $51.44 ...

Repare and CNL plan to leverage the strengths of both organizations which cut across radiobiology, preclinical evaluation, ...

Repare Therapeutics (RPTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts ...

Repare and CNL plan to leverage the strengths of both organizations which cut across radiobiology, preclinical evaluation, ...

CNL’S CNRI-H PROGRAM CONTINUES STRONG GROWTH THANKS TO NEW PROJECTS WITH REPARE THERAPEUTICS AND DEFENCE THERAPEUTICS ...

Canada’s national nuclear laboratories announces new projects with leading Canadian biopharmaceutical companies through collaborative research program ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...